IL166213A0 - N-hydroxyamide derivatives possessing antibacterial activity - Google Patents

N-hydroxyamide derivatives possessing antibacterial activity

Info

Publication number
IL166213A0
IL166213A0 IL16621305A IL16621305A IL166213A0 IL 166213 A0 IL166213 A0 IL 166213A0 IL 16621305 A IL16621305 A IL 16621305A IL 16621305 A IL16621305 A IL 16621305A IL 166213 A0 IL166213 A0 IL 166213A0
Authority
IL
Israel
Prior art keywords
antibacterial activity
derivatives possessing
hydroxyamide derivatives
possessing antibacterial
hydroxyamide
Prior art date
Application number
IL16621305A
Other languages
English (en)
Original Assignee
Vicuron Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vicuron Pharmaceuticals Ltd filed Critical Vicuron Pharmaceuticals Ltd
Publication of IL166213A0 publication Critical patent/IL166213A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL16621305A 2002-07-11 2005-01-10 N-hydroxyamide derivatives possessing antibacterial activity IL166213A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39486202P 2002-07-11 2002-07-11
PCT/US2003/021838 WO2004007444A2 (fr) 2002-07-11 2003-07-11 Derives de n-hydroxyamide ayant une activite anti-bacterienne

Publications (1)

Publication Number Publication Date
IL166213A0 true IL166213A0 (en) 2006-01-15

Family

ID=30115780

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16621305A IL166213A0 (en) 2002-07-11 2005-01-10 N-hydroxyamide derivatives possessing antibacterial activity

Country Status (8)

Country Link
US (1) US7691843B2 (fr)
EP (1) EP1539744A4 (fr)
JP (1) JP4617449B2 (fr)
KR (1) KR101011373B1 (fr)
AU (1) AU2003267991B2 (fr)
CA (1) CA2492035A1 (fr)
IL (1) IL166213A0 (fr)
WO (1) WO2004007444A2 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101076018B1 (ko) 2003-01-08 2011-10-21 유니버시티 오브 워싱톤 항균제
US7638513B2 (en) 2004-06-02 2009-12-29 Schering Corporation Compounds for the treatment of inflammatory disorders
EP1963262A2 (fr) 2005-12-15 2008-09-03 Vicuron Pharmaceuticals, Inc. Derives de n-hydroxyamide possedant une activite antibacterienne
HUE028029T2 (en) 2006-01-30 2016-11-28 Panion & Bf Biotech Inc A method of treating chronic kidney disease
JP2010502617A (ja) * 2006-08-31 2010-01-28 シェーリング コーポレイション 抗菌物質として有用なヒダントイン誘導体
CN107021895A (zh) * 2007-06-12 2017-08-08 尔察祯有限公司 抗菌剂
EP2234608A2 (fr) 2007-12-11 2010-10-06 Viamet Pharmaceuticals, Inc. Inhibiteurs de métalloenzymes utilisant des fractions de liaison à un métal en combinaison avec des fractions de ciblage
WO2011005355A1 (fr) * 2009-05-07 2011-01-13 Achaogen, Inc. Combinaisons comprenant un inhibiteur de lpxc et un antibiotique à utiliser dans le traitement d'infections induites par des bactéries à gram négatif
JP5167389B2 (ja) 2010-07-07 2013-03-21 日本たばこ産業株式会社 クエン酸第二鉄を含む錠剤
US9738604B2 (en) 2010-09-03 2017-08-22 Duke University Ethynylbenzene derivatives
JP2012162522A (ja) 2011-01-18 2012-08-30 Japan Tobacco Inc β酸化水酸化鉄を実質的に含まないクエン酸第二鉄
EP2847168A1 (fr) 2012-05-10 2015-03-18 Achaogen, Inc. Agents antibactériens
US10189786B2 (en) 2013-08-16 2019-01-29 Duke University Antibacterial compounds
WO2015024016A2 (fr) 2013-08-16 2015-02-19 Duke University N,3-dihydroxybutanamides substitués par 2-pipéridinyle
AU2014306451B2 (en) 2013-08-16 2019-01-17 Duke University Substituted hydroxamic acid compounds
CN105646321A (zh) * 2016-01-07 2016-06-08 中国药科大学 (s)-3-羟基吡咯烷盐酸盐的制备方法
WO2017182433A1 (fr) * 2016-04-18 2017-10-26 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Nouveaux inhibiteurs de la méprine alpha et bêta
TW202023386A (zh) 2018-09-13 2020-07-01 瑞士商先正達合夥公司 殺有害生物活性唑-醯胺化合物
JP2022116370A (ja) * 2019-06-13 2022-08-10 アグロカネショウ株式会社 新規な１－ベンジルアミン誘導体及びこれを有効成分とする農園芸用薬剤
WO2021122645A1 (fr) * 2019-12-20 2021-06-24 Syngenta Crop Protection Ag Composés azole-amide à action pesticide
TW202208347A (zh) 2020-05-06 2022-03-01 德商拜耳廠股份有限公司 作為殺蟲劑之新穎雜芳基三唑化合物
CN112410449A (zh) * 2021-01-25 2021-02-26 天津奇云诺德生物医学有限公司 一种与结直肠癌相关的微生物标志物及其应用
CN113413390B (zh) * 2021-06-24 2022-08-30 河南大学 4-脱氧-n-乙酰氨基葡萄糖作为革兰氏阳性菌抗菌添加剂的应用

Family Cites Families (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5098904A (en) 1990-06-27 1992-03-24 Bristol-Myers Squibb Company Cerebral function enhancing pyrimidinyl derivatives
US5488418A (en) * 1991-04-10 1996-01-30 Mitsubishi Denki Kabushiki Kaisha Encoder and decoder
CA2071621C (fr) 1991-06-19 1996-08-06 Ahihiko Hosoda Derives d'aldehyde
US6506876B1 (en) 1994-10-11 2003-01-14 G.D. Searle & Co. LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use
US5798337A (en) 1994-11-16 1998-08-25 Genentech, Inc. Low molecular weight peptidomimetic growth hormone secretagogues
JPH11502224A (ja) 1995-03-17 1999-02-23 藤沢薬品工業株式会社 Ｎ−アシルピペリジニルカルボニルアミノカルボン酸、およびグリコプロテインＩＩＢ／ＩＩＩａ拮抗剤およびフィブリノーゲン血小板凝集抑制剤としてのその用途
MX9709278A (es) 1995-05-29 1998-03-31 Pfizer Dipeptidos que promueven la liberacion de la hormona de crecimiento, composiciones que los contienen y uso de los mismos.
ES2151156T3 (es) * 1995-07-26 2000-12-16 Pfizer Derivados de acidos n-(aroil)glicina hidroxamicos y compuestos relacionados.
US5997881A (en) 1995-11-22 1999-12-07 University Of Maryland, Baltimore Method of making non-pyrogenic lipopolysaccharide or A
EP0923555B1 (fr) 1996-05-01 2005-06-15 Ortho-McNeil Pharmaceutical, Inc. Derives carboxamide de pyrrolidine, piperidine et hexahydroazepine utilises dans le traitement de troubles thrombotiques
US5925659A (en) 1996-05-07 1999-07-20 Merck & Co., Inc. Antibacterial agents
DE19642591A1 (de) 1996-10-15 1998-04-16 Basf Ag Neue Piperidin-Ketocarbonsäure-Derivate, deren Herstellung und Anwendung
DE19647381A1 (de) 1996-11-15 1998-05-20 Hoechst Ag Neue Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten
TW542822B (en) 1997-01-17 2003-07-21 Ajinomoto Kk Benzamidine derivatives
PT966447E (pt) 1997-03-03 2003-07-31 Boehringer Ingelheim Pharma Moleculas pequenas uteis no tratamento de doencas inflamatorias
AR011913A1 (es) 1997-03-06 2000-09-13 Yamano Masaki Derivados de 4,4-difluoro-2,3,4,5-tetrahidro-1h-1-benzoazepina y composiciones farmaceuticas de los mismos.
US6492421B1 (en) 1997-07-31 2002-12-10 Athena Neurosciences, Inc. Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4
NZ502872A (en) 1997-08-28 2002-10-25 Novartis Ag Mevinolin and compaction as LFA-1 antagonists for treating autoimmune diseases
US20010039287A1 (en) 1997-11-14 2001-11-08 Thomas E Barta Aromatic sulfone hydroxamic acid metalloprotease inhibitor
AU1415099A (en) 1997-11-18 1999-06-07 Merck & Co., Inc. 4-substituted-4-piperidine carboxamide derivatives
US6020347A (en) 1997-11-18 2000-02-01 Merck & Co., Inc. 4-substituted-4-piperidine carboxamide derivatives
DE19751251A1 (de) 1997-11-19 1999-05-20 Hoechst Marion Roussel De Gmbh Substituierte Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmezeutische Präparate
US6191171B1 (en) 1997-11-20 2001-02-20 Merck & Co., Inc. Para-aminomethylaryl carboxamide derivatives
WO1999026923A1 (fr) 1997-11-20 1999-06-03 Merck & Co., Inc. Derives de carboxamide de para-aminomethylaryl
EP1048652A4 (fr) 1997-12-26 2001-05-09 Mochida Pharm Co Ltd Composes aromatiques presentant des groupements amino cycliques ou leur sels
US6407065B1 (en) 1998-01-23 2002-06-18 Novartis Ag VLA-4 antagonists
JP2002511239A (ja) 1998-04-14 2002-04-16 バーシコー， インコーポレイテッド スクリーニングのための調節された標的発現
EP1085846A2 (fr) 1998-06-08 2001-03-28 Advanced Medicine, Inc. Inhibiteurs multiliaison de proteine triglyceride transferase microsomique
TW591026B (en) 1998-06-23 2004-06-11 Upjohn Co Inhibitors of alpha4beta1 mediated cell adhesion
AU4701799A (en) * 1998-07-21 2000-02-14 Warner-Lambert Company Coadministration of ACAT and MMP inhibitors for the treatment of atherosclerotic lesions
US6331640B1 (en) 1998-10-13 2001-12-18 Hoffmann-La Roche Inc. Diaminopropionic acid derivatives
EP1004578B1 (fr) 1998-11-05 2004-02-25 Pfizer Products Inc. Dérivés d'hydroxamide de l'acide 5-oxo-pyrrolidine-2-carboxylique
US6110922A (en) 1998-12-29 2000-08-29 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
AR035476A1 (es) 1999-01-22 2004-06-02 Elan Pharm Inc Compuestos heteroarilo y heterociclicos con anillo fusionado, los cuales inhiben la adhesion de leucocitos mediada por vla-4, composiciones farmaceuticas, el uso de las mismas para la manufactura de un medicamento y un metodo para fijar vla-4 en una muestra biologica
CN1231212C (zh) 1999-01-22 2005-12-14 依兰制药公司 抑制vla－4介导的白细胞粘着的多环化合物
NZ515238A (en) 1999-04-02 2005-02-25 Icos Corp Inhibitors of LFA-1 binding to ICAMs and uses thereof
UA74781C2 (en) 1999-04-02 2006-02-15 Abbott Lab Antiinflammatory and immumosuppressive compounds inhibiting cell adhesion
AU4192000A (en) 1999-04-02 2000-10-23 Abbott Laboratories Lfa-1 regulatory binding site and uses thereof
WO2001000616A1 (fr) 1999-06-25 2001-01-04 Mochida Pharmaceutical Co., Ltd. Inhibiteurs de la biosynthese du cholesterol contenant comme ingredient actif des composes aromatiques porteurs de groupes cycliques amino
US6353013B1 (en) 1999-07-21 2002-03-05 Boehringer Ingelheim Pharmaceuticals, Inc. Small molecules useful in the treatment of inflammatory disease
WO2001007048A1 (fr) 1999-07-21 2001-02-01 Boehringer Ingelheim Pharmaceuticals, Inc. Petites molecules utiles pour le traitement de troubles inflammatoires
WO2001007052A1 (fr) 1999-07-21 2001-02-01 Boehringer Ingelheim Pharmaceuticals, Inc. Petites molecules des plus utiles dans le traitement de maladies inflammatoires
WO2001006984A2 (fr) 1999-07-21 2001-02-01 Boehringer Ingelheim Pharmaceuticals, Inc. Petites particules utiles pour le traitement de maladies inflammatoires
US6420418B1 (en) 1999-08-16 2002-07-16 Merck & Co., Inc. Heterocycle amides as cell adhesion inhibitors
WO2001014328A2 (fr) 1999-08-20 2001-03-01 Merck & Co., Inc. Urees substituees inhibiteurs d'adhesion cellulaire
CA2383773A1 (fr) 1999-09-01 2001-03-08 Boehringer Ingelheim Pharmaceuticals, Inc. Methodes et compositions destinees au traitement des maladies auto-immunes
ES2244474T3 (es) 1999-09-29 2005-12-16 Ortho-Mcneil Pharmaceutical, Inc. Isonipecotamida para el tratamiento de trastornos mediados por integrina.
KR100496940B1 (ko) 1999-10-20 2005-06-23 다나베 세이야꾸 가부시키가이샤 αＬβ2 개재된 세포 접착 억제제
US6458822B2 (en) 2000-03-13 2002-10-01 Pfizer Inc. 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
JP2003528088A (ja) 2000-03-23 2003-09-24 メルク エンド カムパニー インコーポレーテッド メラノコルチン受容体作働薬としての置換ピペリジン類
DE50111799D1 (de) 2000-04-08 2007-02-15 Boehringer Ingelheim Pharma Bicyclische heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
US6627634B2 (en) 2000-04-08 2003-09-30 Boehringer Ingelheim Pharma Kg Bicyclic heterocycles, pharmaceutical compositions containing them, their use, and processes for preparing them
US6482840B2 (en) 2000-05-22 2002-11-19 Merck & Co., Inc. Substituted cyclic amidine derivatives as inhibitors of cell adhesion
PT1284973E (pt) 2000-05-31 2007-08-17 Tanabe Seiyaku Co ''inibidores de adesão celular mediada por alfa l beta 2''
US6579889B2 (en) 2000-06-22 2003-06-17 Merck & Co., Inc. Substituted isonipecotyl derivatives as inhibitors of cell adhesion
EP1294685A1 (fr) 2000-06-29 2003-03-26 Abbott Laboratories Derives de sulfure d'aryle phenycyclopropyle et leur utilisation en tant que composes anti-inflammatoires inhibant l'adhesion cellulaire et agents immunosuppresseurs
AU2001282938A1 (en) 2000-07-21 2002-02-05 Elan Pharmaceuticals, Inc. Alpha amino acid derivatives--inhibitors of leukocyte adhesion mediated by vla-4
US6689781B2 (en) 2000-07-21 2004-02-10 Elan Pharmaceuticals, Inc. Phenylalanine derivatives as alpha 4 integrin inhibitors
US7015216B2 (en) 2000-07-21 2006-03-21 Elan Pharmaceuticals, Inc. Heteroaryl-β-alanine derivatives as alpha 4 integrin inhibitors
AU2002248432A1 (en) 2001-02-14 2002-08-28 Sankyo Company, Limited Oxazole derivatives, their preparation and their use as cytokine inhibitors
GB2377933A (en) 2001-07-06 2003-01-29 Bayer Ag Succinic acid derivatives useful as integrin antagonists
WO2003007949A1 (fr) 2001-07-18 2003-01-30 Merck & Co., Inc. Derives de piperidine pontee utilises comme agonistes du recepteur de la melanocortine
JP2005022976A (ja) 2001-07-18 2005-01-27 Ajinomoto Co Inc カルボン酸誘導体
US6646130B2 (en) 2001-07-19 2003-11-11 Merck & Co., Inc. Process to chiral integrin antagonist beta-amino acid intermediate
DE10137595A1 (de) 2001-08-01 2003-02-13 Aventis Pharma Gmbh Neue Imidazolidinderivate, ihre Herstellung und ihre Verwendung
KR101076018B1 (ko) 2003-01-08 2011-10-21 유니버시티 오브 워싱톤 항균제
EP1963262A2 (fr) 2005-12-15 2008-09-03 Vicuron Pharmaceuticals, Inc. Derives de n-hydroxyamide possedant une activite antibacterienne

Also Published As

Publication number Publication date
AU2003267991A1 (en) 2004-02-02
EP1539744A2 (fr) 2005-06-15
WO2004007444A2 (fr) 2004-01-22
US7691843B2 (en) 2010-04-06
JP2005536510A (ja) 2005-12-02
US20080058304A1 (en) 2008-03-06
WO2004007444A3 (fr) 2004-09-10
AU2003267991B2 (en) 2009-10-08
EP1539744A4 (fr) 2007-06-06
KR20050023412A (ko) 2005-03-09
KR101011373B1 (ko) 2011-01-28
CA2492035A1 (fr) 2004-01-15
JP4617449B2 (ja) 2011-01-26

Similar Documents

Publication Publication Date Title
IL166213A0 (en) N-hydroxyamide derivatives possessing antibacterial activity
SI1583763T1 (sl) Benzoazolilpiperazinski derivati, ki imajo VR1 antagonistično delovanje
IL172183A0 (en) Novel lincomycin derivatives possessing antimicrobial activity
IL166476A0 (en) Lincomycin derivatives possessing antibacterial activity
AU2003282779A1 (en) Antibacterial agents
AU2003300965A1 (en) Antibacterial agents
HK1091491A1 (en) Pyrrol derivatives with antibacterial activity
AU2003282268A1 (en) Activity monitoring
AU2003218997A1 (en) Macrolides with antibacterial activity
AU2003280129A1 (en) Activity monitoring
AU7638901A (en) Pleuromutilin derivatives having antibacterial activity
IL162930A0 (en) Wireless ecg system
AU2003288248A1 (en) Dihalo-allyloxy-phenol derivatives having pesticidal activity
AU2003288459A1 (en) Antibacterial agents
AU2003224345A1 (en) Antibacterial agents
AU2003290684A1 (en) Novel anhydrolide derivatives having antibacterial activity
AU2003217072A1 (en) Antibacterial agents
AU2003224274A1 (en) Human polypeptides having antibacterial activity
AU2002349137A1 (en) Antibacterial agents
AU2003285545A1 (en) Antibacterial agents
GB0204703D0 (en) Antibacterial agent
GB0204853D0 (en) Antibacterial compounds
GB0210439D0 (en) Antibacterial compounds
GB0221809D0 (en) Antibiotic derivatives
HUP0204362D0 (en) Compounds having pharmaceutical activity